News
EU first to clear AbbVie's Rinvoq for alopecia areata
AbbVie's fast-growing JAK inhibitor Rinvoq has been cleared for alopecia areata in the EU, its first market for the hair loss disorder.
News
J&J's oral IL-23 drug backed for psoriasis in EU
J&J's oral psoriasis drug Icotyde heads up the list of new therapies recommended for EU approval at the CHMP's July meeting.
News
Outlook finally claims FDA approval for AMD drug
After three knockbacks by the FDA, Outlook has finally pushed its therapy for age-related macular degeneration over the finish line in the US.
News
Re-rostered FDA committee backs peptide compounding
Against the advice of FDA staff scientists, an advisory committee has narrowly voted in support of looser restrictions on compounded peptides.
News
EU clears AZ's SERD camizestrant, as FDA review drags on
AstraZeneca's new breast cancer therapy Etcamah claims landmark frontline approval in the EU, but its prospects in the US are less certain.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
